Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Developmental Dynamics : an Official Publication of the American Association of Anatomists|May 23, 2003
Phenotype of the zebrafish masterblind (mbl) mutant is dependent on genetic backgroundL H Sanders, K E WhitlockBioorganic & Medicinal Chemistry|October 1, 1995
Comparative molecular field analysis of selective A3 adenosine receptor agonistsS M Siddiqi, R A Pearlstein, L H Sanders, et al.Journal of Medicinal Chemistry|January 23, 1998
Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis modelS Moro, A M van Rhee, L H Sanders, et al.American Journal of Hospital Pharmacy|May 1, 1978
Evaluation of compounding accuracy and aseptic techniques for intravenous admixturesL H Sanders, S A Mabadeje, K E Avis, et al.Scientific Reports|October 15, 2020
Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson's diseaseC P Gonzalez-Hunt, E A Thacker, C M Toste, et al.Heart, Lung & Circulation|July 18, 2016
Surgical Pulmonary Embolectomy: Experience in a Series of 37 Consecutive CasesJ J Edelman, N Okiwelu, K Anvardeen, et al.Journal of Medicinal Chemistry|March 4, 1994
Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonistsC Gallo-Rodriguez, X D Ji, N Melman, et al.Free Radical Research|March 6, 2015
LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's diseaseY Y Tyurina, A M Polimova, E Maciel, et al.Nature Communications|November 20, 2018
Age-related declines in α-Klotho drive progenitor cell mitochondrial dysfunction and impaired muscle regenerationA Sahu, H Mamiya, S N Shinde, et al.Pageof 1